[Federal Register Volume 88, Number 240 (Friday, December 15, 2023)]
[Notices]
[Pages 86903-86904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27549]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-1186; Docket No. CDC-2023-0099]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Information Collection for Tuberculosis Data from Referring 
Entities to CureTB. The CureTB program works to prevent the spread of 
tuberculosis (TB) among people who cross international borders by 
providing linkage to care for patients with active/suspected TB when 
they leave the U.S., accurate and up-to-date information for receiving 
providers, motivation and resources for mobile individuals to continue 
care, linkage for comorbidities, and facilitation of positive outcomes 
and communication between partners.

DATES: CDC must receive written comments on or before February 13, 
2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0099 by either of the following methods:
    <bullet> Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: <a href="/cdn-cgi/l/email-protection#9af5f7f8daf9fef9b4fdf5ec"><span class="__cf_email__" data-cfemail="16797b745675727538717960">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Information Collection for Tuberculosis Data from Referring 
Entities to CureTB (OMB Control No. 0920-1186, Exp. 2/29/2024)--
Extension--National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The CureTB program at CDC works to prevent the spread of 
tuberculosis (TB) among people who cross international borders. To 
reduce disease transmission and the emergence of drug-resistant TB,

[[Page 86904]]

CureTB connects people with TB to healthcare services as they move 
between the United States and other countries. The program is a 
collaboration between CDC's Division of Global Migration Health (DGMH) 
and the County of San Diego's Tuberculosis Control Program. CureTB 
collaborates with health authorities throughout the United States and 
around the world to link people with TB to care at their destinations. 
Health departments, healthcare providers, and others seeking help in 
linking patients to ongoing TB care in other countries can refer 
patients to CureTB. CureTB has an interagency agreement with ICE 
(Immigration and Custom Enforcement) to refer those patients with 
suspected or confirmed TB when they are repatriated to their countries 
of origin.
    CureTB collects the following types of information: (1) referring 
entities (referring agency and jurisdiction) information including name 
of referring person, telephone numbers, fax numbers, email addresses; 
(2) patient's name and last name(s), demographics date of birth, 
gender, address (U.S. and outside of the U.S), telephone numbers, email 
address, patient's contact persons including name and telephone number; 
and (3) TB clinical information, including diagnostic testing 
(radiology reports, laboratory testing reports, other diagnostic 
methods used, treatment regimen and information about comorbidities).
    CDC is requesting OMB approval for an additional three years. CDC 
requests approval for an estimated 1,125 annual burden hours. There is 
not cost to respondents other than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                            Average
                                                              Number of      Number of     burden per    Total
        Type of respondents                 Form name        respondents   responses per    response     burden
                                                                            respondent     (in hours)    hours
----------------------------------------------------------------------------------------------------------------
U.S. health departments............  CureTB Transnational             80               4        30/60        160
                                      Notification.
TB patients referred by U.S. health  CureTB Transnational            214               1         5/60         18
 departments.                         Notification.
Tb patients referred by ICE........  CureTB Transnational            587               1        45/60        440
                                      Notification.
TB treating physicians in new        CureTB Clinician                870               3        10/60        435
 country.                             Public Health
                                      Department Follow-up
                                      Script.
U.S. health departments............  CureTB Contact/Source            20               5        30/60         50
                                      Investigation (CI/CS)
                                      Notification.
U.S. health departments............  CureTB Program Partner          100               1        10/60         17
                                      Satisfaction
                                      Assessment
                                      Questionnaire 1.
U.S. health departments............  CureTB Program Partner           50               1         6/60          5
                                      Satisfaction
                                      Assessment
                                      Questionnaire 2.
                                                            ----------------------------------------------------
    Total..........................  ......................  ...........  ..............  ...........      1,125
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-27549 Filed 12-14-23; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>